College of American Pathologists Release: Revisions to Molecular Testing Guidelines Continues To Give Hope To Lung Cancer Patients

BETHESDA, Md.--(BUSINESS WIRE)--The College of American Pathologists (CAP), the International Association for the Study of Lung Cancer (IASLC), and the Association for Molecular Pathology (AMP) are teaming to revise the evidence-based guideline, “Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors.”

Help employers find you! Check out all the jobs and post your resume.